Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations J Clin Epidemiol. Wang L et al.   Great to see this abstract!  Without the abstract I’m not sure how rapid ‘rapid’ actually is. Also, it’s unclear how close the results were, aside from the very nice ‘tease’ of: “Compared to an NMA including all unique trials, we … Continue reading Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations